• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究与 COVID-19 后急性后遗症相关的病毒和自身免疫性 T 细胞反应。

Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19.

机构信息

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA.

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; University of California San Diego School of Medicine, La Jolla, San Diego, CA, USA.

出版信息

Hum Immunol. 2024 May;85(3):110770. doi: 10.1016/j.humimm.2024.110770. Epub 2024 Mar 2.

DOI:10.1016/j.humimm.2024.110770
PMID:38433036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11144566/
Abstract

Post-acute sequelae of COVID-19 (PASC), or Long COVID, is a chronic condition following acute SARS-CoV-2 infection. Symptoms include exertion fatigue, respiratory issues, myalgia, and neurological manifestations such as 'brain fog,' posing concern for their debilitating nature and potential role in other neurological disorders. However, the underlying potential pathogenic mechanisms of the neurological complications of PASC is largely unknown. Herein, we investigated differences in antigen-specific T cell responses from the peripheral blood towards SARS-CoV-2, latent viruses, or neuronal antigens in 14 PASC individuals with neurological manifestations (PASC-N) versus 22 individuals fully recovered from COVID-19. We employed Activation Induced Marker (AIM), ICS and FluoroSpot assays to determine the specificity and magnitude of CD4 and CD8 T cell responses towards SARS-CoV-2 (Spike and rest of proteome), latent viruses (CMV, EBV), and several neuronal antigens. Overall, we observed similar antigen-specific T cell frequencies and cytokine effector T cell responses between PASC donors compared to recovered controls for all antigens tested (viral or autoantigen) in both CD4 and CD8 T cell compartments. Our findings suggest that PASC-N does not appear to be associated with changes in antigen-specific T cell responses towards a subset of disease-relevant targets, but more studies in a larger cohort are needed to confirm these unaltered responses.

摘要

新冠病毒感染后出现的长期后遗症(PASC),又称“长新冠”,是急性 SARS-CoV-2 感染后的一种慢性疾病。其症状包括劳累后疲劳、呼吸问题、肌肉疼痛和神经表现,如“脑雾”,这令人担忧其虚弱的性质和在其他神经障碍中的潜在作用。然而,PASC 神经并发症的潜在发病机制在很大程度上是未知的。在此,我们研究了 14 名有神经表现的 PASC 个体(PASC-N)与 22 名从 COVID-19 中完全康复的个体的外周血针对 SARS-CoV-2、潜伏病毒或神经元抗原的抗原特异性 T 细胞反应的差异。我们采用活化诱导标记物(AIM)、ICS 和 FluoroSpot 测定法来确定针对 SARS-CoV-2(Spike 和其余蛋白质组)、潜伏病毒(CMV、EBV)和几种神经元抗原的 CD4 和 CD8 T 细胞反应的特异性和强度。总体而言,与恢复期对照组相比,PASC 供体针对所有测试抗原(病毒或自身抗原)的 CD4 和 CD8 T 细胞中,针对 SARS-CoV-2 的抗原特异性 T 细胞频率和细胞因子效应 T 细胞反应相似。我们的研究结果表明,PASC-N 似乎与针对一组疾病相关靶标的抗原特异性 T 细胞反应的变化无关,但需要更多更大队列的研究来证实这些未改变的反应。

相似文献

1
Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19.研究与 COVID-19 后急性后遗症相关的病毒和自身免疫性 T 细胞反应。
Hum Immunol. 2024 May;85(3):110770. doi: 10.1016/j.humimm.2024.110770. Epub 2024 Mar 2.
2
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4 immune responses.新冠后遗症与持续的新冠病毒特异性CD4免疫反应有关。
Int Immunopharmacol. 2025 Feb 20;148:114103. doi: 10.1016/j.intimp.2025.114103. Epub 2025 Jan 27.
3
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.从 COVID-19 中康复且伴有和不伴有急性后期症状的个体的 SARS-CoV-2 特异性免疫和炎症反应的长期变化。
Cell Rep. 2021 Aug 10;36(6):109518. doi: 10.1016/j.celrep.2021.109518. Epub 2021 Aug 6.
4
Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.神经 PAS 以增强的针对 SARS-CoV-2 核衣壳蛋白的 CD4+和减少的 CD8+T 细胞反应为特征。
Front Immunol. 2023 May 29;14:1155770. doi: 10.3389/fimmu.2023.1155770. eCollection 2023.
5
Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.人疱疹病毒再激活及其在新型冠状病毒肺炎感染后急性后遗症发病机制中的潜在作用。
Geroscience. 2025 Feb;47(1):167-187. doi: 10.1007/s11357-024-01323-9. Epub 2024 Aug 29.
6
PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females.COVID-19 后急性后遗症(PASC)与两性的中和抗体滴度降低有关,并与女性的 ANG-2 和 GM-CSF 增加有关。
Sci Rep. 2024 Apr 29;14(1):9854. doi: 10.1038/s41598-024-60089-4.
7
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).SARS-CoV-2 感染后后遗症(PASC)的发病机制。
Elife. 2023 Mar 22;12:e86002. doi: 10.7554/eLife.86002.
8
A Disease Hidden in Plain Sight: Pathways and Mechanisms of Neurological Complications of Post-acute Sequelae of COVID-19 (NC-PASC).一种隐匿于众目睽睽之下的疾病:新冠后急性后遗症(NC-PASC)的神经并发症途径与机制
Mol Neurobiol. 2025 Feb;62(2):2530-2547. doi: 10.1007/s12035-024-04421-z. Epub 2024 Aug 12.
9
Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC).在儿童新冠病毒感染后长期后遗症(PASC)中,SARS-CoV-2 反应性低亲和力 T 细胞增加,并产生炎症细胞因子。
Pediatr Allergy Immunol. 2023 Dec;34(12):e14060. doi: 10.1111/pai.14060.
10
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.HIV 感染者在 SARS-COV-2 感染后出现的后遗症和适应性免疫反应。
AIDS. 2022 Oct 1;36(12):F7-F16. doi: 10.1097/QAD.0000000000003338. Epub 2022 Jul 18.

引用本文的文献

1
Immunological and Clinical Markers of Post-acute Sequelae of COVID-19: Insights from Mild and Severe Cases 6 Months Post-infection.新型冠状病毒肺炎急性后遗症的免疫和临床标志物:感染后6个月轻症和重症病例的见解
Eur J Immunol. 2025 Jul;55(7):e51948. doi: 10.1002/eji.202551948.
2
Identification of an immunological signature of long COVID syndrome.长新冠综合征免疫特征的鉴定。
Front Immunol. 2025 Jan 8;15:1502937. doi: 10.3389/fimmu.2024.1502937. eCollection 2024.
3
Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.

本文引用的文献

1
The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses.MegaPool 方法分析适应性 CD4+和 CD8+T 细胞应答。
Curr Protoc. 2023 Nov;3(11):e934. doi: 10.1002/cpz1.934.
2
Distinguishing features of long COVID identified through immune profiling.通过免疫分析鉴定出长新冠的特征。
Nature. 2023 Nov;623(7985):139-148. doi: 10.1038/s41586-023-06651-y. Epub 2023 Sep 25.
3
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).COVID-19 后急性后遗症(PASC)中的 SARS-CoV-2 储主。
人疱疹病毒再激活及其在新型冠状病毒肺炎感染后急性后遗症发病机制中的潜在作用。
Geroscience. 2025 Feb;47(1):167-187. doi: 10.1007/s11357-024-01323-9. Epub 2024 Aug 29.
Nat Immunol. 2023 Oct;24(10):1616-1627. doi: 10.1038/s41590-023-01601-2. Epub 2023 Sep 4.
4
SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic.奥密克戎变异株流行后期的 SARS-CoV-2 再感染和长新冠
Int J Mol Sci. 2023 Aug 19;24(16):12962. doi: 10.3390/ijms241612962.
5
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.新冠病毒感染后持续存在的症状与 SARS-CoV-2 抗体或 T 细胞免疫无差异相关。
Nat Commun. 2023 Aug 23;14(1):5139. doi: 10.1038/s41467-023-40460-1.
6
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.常见的 HLA 等位基因与无症状 SARS-CoV-2 感染相关。
Nature. 2023 Aug;620(7972):128-136. doi: 10.1038/s41586-023-06331-x. Epub 2023 Jul 19.
7
Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.神经 PAS 以增强的针对 SARS-CoV-2 核衣壳蛋白的 CD4+和减少的 CD8+T 细胞反应为特征。
Front Immunol. 2023 May 29;14:1155770. doi: 10.3389/fimmu.2023.1155770. eCollection 2023.
8
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).SARS-CoV-2 感染后后遗症(PASC)的发病机制。
Elife. 2023 Mar 22;12:e86002. doi: 10.7554/eLife.86002.
9
The role of immune activation and antigen persistence in acute and long COVID.免疫激活和抗原持续存在在急性和长新冠中的作用。
J Investig Med. 2023 Jun;71(5):545-562. doi: 10.1177/10815589231158041. Epub 2023 Mar 6.
10
T Cell Responses to SARS-CoV-2.T细胞对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的反应。
Annu Rev Immunol. 2023 Apr 26;41:343-373. doi: 10.1146/annurev-immunol-101721-061120. Epub 2023 Feb 7.